A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma-Reference-Cited by-同舟云学术

A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma

Published:2023-04-23 Issue:1 Volume:15 Page:
ISSN:1949-0976
Container-title:Gut Microbes
language:en
Short-container-title:Gut Microbes

Author:

Yang Jinhuan¹,He Qikuan¹,Lu Fei²,Chen Kaiwen¹,Ni ZhiHao³,Wang Haoyue⁴,Zhou Chen²,Zhang Yaosheng²,Chen Bo¹,Bo Zhiyuan¹,Li Jialiang¹,Yu Haitao¹,Wang Yi⁵,Chen Gang¹⁶

Affiliation:

1. Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

2. The First School of Medicine, School of Information and Engineering, Wenzhou Medical University, Wenzhou, China

3. School of Nursing, Wenzhou Medical University, Wenzhou, China

4. School of Mental Health, Wenzhou Medical University, Wenzhou, China

5. Department of Epidemiology and Biostatistics, School of Public Health and Management, Wenzhou Medical University; Chashan High Education Zone, Wenzhou, China

6. Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

Funder

National Natural Science Foundation of China

the Research Foundation of the National Health Commission of China–Major Medical and Health Technology Project for Zhejiang Province

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),Gastroenterology,Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/19490976.2023.2201159

Reference59 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases